Effects of KCNQ Potassium Channel Blockers on Pulmonary Arteries
Author Information
Author(s): Shreena Joshi, Prabhu Balan, Alison M Gurney
Primary Institution: University of Strathclyde and University of Manchester
Hypothesis
KCNQ channels may play a role in regulating the function of pulmonary arteries.
Conclusion
KCNQ channel blockers are potent constrictors of pulmonary arteries, acting directly on smooth muscle cells.
Supporting Evidence
- Linopirdine and XE991 contracted rat and mouse pulmonary arteries significantly.
- The maximum contraction was almost as large as the response to 50 mM K+.
- Contraction was abolished in Ca2+-free solution, indicating a dependence on Ca2+ influx.
Takeaway
Two drugs, linopirdine and XE991, can make blood vessels in the lungs squeeze tighter, which might be important for understanding how to treat certain lung problems.
Methodology
The study measured the tension developed by rat and mouse pulmonary arteries using small vessel myography and tested the effects of KCNQ channel blockers.
Limitations
The study primarily focused on isolated arteries and may not fully represent in vivo conditions.
Participant Demographics
Male Sprague Dawley rats (250–300 g) and BALB/c mice (4–5 weeks old) were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website